Skip to main content

Advertisement

Table 3 Densitometry analysis of the SDF-1 expression on the lungs of the representative images from Figure 4 Ci-v

From: Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches

  IntDen StdDev %Area
Secondary negative control 32.97** 30.27 0.3
Balb/C with no tumor 1001.25* 26.59 1.23
SKG with no tumor 1154.60* 25.53 1.98
SKG + BC + IgG 4249.27 21.13 25.49
SKG + BC + anti-IL-17A 1179.99* 24.97 4.49
  1. (i) Secondary antibody only; (ii) Balb/C with no tumor and no AA; (iii) SKG with no tumor; (iv) 4 T1 tumor bearing SKG mice treated with control IgG antibody or with anti-IL-17A antibody (v) (*P < 0.05: Balb/C, SKG, SKG + BC + anti-IL-17A against SKG + BC + IgG; **P < 0.01: Secondary antibody against all other groups).